{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:27:17Z","timestamp":1794324437500,"version":"4.9.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10096-021-04391-3","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T19:03:47Z","timestamp":1641495827000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Acute kidney injury in Staphylococcus aureus bacteremia"],"prefix":"10.1007","volume":"41","author":[{"given":"Annette C.","family":"Westgeest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile F.","family":"Schippers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie M.","family":"Delfos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G. J.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel M. C.","family":"Lambregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"6","key":"4391_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s15010-019-01330-5","volume":"47","author":"JC Lam","year":"2019","unstructured":"Lam JC, Gregson DB, Robinson S, Somayaji R, Conly JM, Parkins MD (2019) Epidemiology and outcome determinants of Staphylococcus aureus bacteremia revisited: a population-based study. Infection 47(6):961\u2013971","journal-title":"Infection"},{"issue":"11","key":"4391_CR2","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/cid\/ciz112","volume":"69","author":"M Souli","year":"2019","unstructured":"Souli M, Ruffin F, Choi SH, Park LP, Gao S, Lent NC et al (2019) Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, longitudinal study. Clin Infect Dis 69(11):1868\u20131877","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4391_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12879-018-3011-2","volume":"18","author":"NE Holmes","year":"2018","unstructured":"Holmes NE, Robinson JO, van Hal SJ, Munckhof WJ, Athan E, Korman TM et al (2018) Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia. BMC Infect Dis 18(1):107","journal-title":"BMC Infect Dis"},{"issue":"6","key":"4391_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.2020.0103","volume":"323","author":"SYC Tong","year":"2020","unstructured":"Tong SYC, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J et al (2020) Effect of vancomycin or daptomycin with vs without an Antistaphylococcal beta-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA 323(6):527\u2013537","journal-title":"JAMA"},{"issue":"13","key":"4391_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2014.9743","volume":"312","author":"TL Holland","year":"2014","unstructured":"Holland TL, Arnold C, Fowler VG Jr (2014) Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 312(13):1330\u20131341","journal-title":"JAMA"},{"issue":"12","key":"4391_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1473-3099(20)30590-9","volume":"20","author":"SYC Tong","year":"2020","unstructured":"Tong SYC, Lee TC (2020) Staphylococcus aureus bacteraemia: does duration matter? Lancet Infect Dis 20(12):1353\u20131354","journal-title":"Lancet Infect Dis"},{"key":"4391_CR7","doi-asserted-by":"crossref","unstructured":"Lambregts MMC, Molendijk EBD, Meziyerh S, Schippers EF, Delfos NM, Leendertse M, et al. Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia: potential value and limitations of a clinical risk score. Int J Clin Pract. 2020:e13601.","DOI":"10.1111\/ijcp.13601"},{"issue":"3","key":"4391_CR8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/01.CCM.0000057403.73299.A6","volume":"31","author":"RP Dellinger","year":"2003","unstructured":"Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31(3):946\u2013955","journal-title":"Crit Care Med"},{"issue":"4","key":"4391_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633\u2013638","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4391_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000499033","volume":"63","author":"CC Burrelli","year":"2018","unstructured":"Burrelli CC, Broadbent EK, Margulis A, Snyder GM, Gold HS, McCoy C et al (2018) Does the beta-lactam matter? Nafcillin versus cefazolin for methicillin-susceptible Staphylococcus aureus Bloodstream Infections. Chemotherapy 63(6):345\u2013351","journal-title":"Chemotherapy"},{"issue":"2","key":"4391_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40121-017-0148-z","volume":"6","author":"LK Flynt","year":"2017","unstructured":"Flynt LK, Kenney RM, Zervos MJ, Davis SL (2017) The safety and economic impact of cefazolin versus nafcillin for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections. Infect Dis Ther 6(2):225\u2013231","journal-title":"Infect Dis Ther"},{"issue":"2","key":"4391_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jmii.2018.07.006","volume":"53","author":"MA Miller","year":"2020","unstructured":"Miller MA, Fish DN, Barber GR, Barron MA, Goolsby TA, Moine P et al (2020) A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections. J Microbiol Immunol Infect 53(2):321\u2013327","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"4391_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jiph.2018.02.004","volume":"11","author":"ML Monogue","year":"2018","unstructured":"Monogue ML, Ortwine JK, Wei W, Eljaaly K, Bhavan KP (2018) Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia. J Infect Public Health 11(5):727\u2013731","journal-title":"J Infect Public Health"},{"issue":"3","key":"4391_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cid\/ciu301","volume":"59","author":"I Youngster","year":"2014","unstructured":"Youngster I, Shenoy ES, Hooper DC, Nelson SB (2014) Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis 59(3):369\u2013375","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4391_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40620-017-0452-4","volume":"31","author":"F Fani","year":"2018","unstructured":"Fani F, Regolisti G, Delsante M, Cantaluppi V, Castellano G, Gesualdo L et al (2018) Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. J Nephrol 31(3):351\u2013359","journal-title":"J Nephrol"},{"issue":"6","key":"4391_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ekir.2020.03.005","volume":"5","author":"S Peerapornratana","year":"2020","unstructured":"Peerapornratana S, Priyanka P, Wang S, Smith A, Singbartl K, Palevsky PM et al (2020) Sepsis-associated acute kidney disease. Kidney Int Rep 5(6):839\u2013850","journal-title":"Kidney Int Rep"},{"issue":"6","key":"4391_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/597031","volume":"48","author":"SE Cosgrove","year":"2009","unstructured":"Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP et al (2009) Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 48(6):713\u2013721","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4391_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1086\/605287","volume":"49","author":"JB Bruss","year":"2009","unstructured":"Bruss JB (2009) Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis. Clin Infect Dis. 49(5):806 (author reply 7-8)","journal-title":"Clin Infect Dis."},{"key":"4391_CR19","unstructured":"Microbiologie NVvM. Guideline Staphylococcus aureus bacteraemia 2021 [Available from: https:\/\/www.nvmm.nl\/media\/3123\/clean-richtlijn-s-aureus-bacteriemie-24-mei-2019.pdf."},{"issue":"7","key":"4391_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmi.2019.03.010","volume":"25","author":"S Weis","year":"2019","unstructured":"Weis S, Kesselmeier M, Davis JS, Morris AM, Lee S, Scherag A et al (2019) Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 25(7):818\u2013827","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"4391_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J (2001) Drug-induced acute interstitial nephritis. Kidney Int 60(2):804\u2013817","journal-title":"Kidney Int"},{"issue":"5","key":"4391_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1086\/520304","volume":"26","author":"JP Gagliardi","year":"1998","unstructured":"Gagliardi JP, Nettles RE, McCarty DE, Sanders LL, Corey GR, Sexton DJ (1998) Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis 26(5):1165\u20131168","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4391_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.kint.2018.08.036","volume":"95","author":"EJ See","year":"2019","unstructured":"See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR et al (2019) Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int 95(1):160\u2013172","journal-title":"Kidney Int"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04391-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04391-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04391-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:14:02Z","timestamp":1644480842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04391-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4391"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04391-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by the institutional ethical review committee of the Leiden University Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}